SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,464 | -57.1% | 39,119 | -7.1% | 0.00% | -50.0% |
| Q2 2023 | $54,744 | -31.6% | 42,111 | +158.5% | 0.00% | -60.0% |
| Q3 2022 | $80,000 | -72.8% | 16,290 | -67.8% | 0.01% | -58.3% |
| Q1 2022 | $294,000 | +39.3% | 50,600 | +80.1% | 0.01% | +33.3% |
| Q4 2021 | $211,000 | -26.5% | 28,100 | -11.9% | 0.01% | -43.8% |
| Q3 2021 | $287,000 | -54.3% | 31,908 | -39.1% | 0.02% | -60.0% |
| Q2 2021 | $628,000 | +115.1% | 52,424 | +125.2% | 0.04% | +185.7% |
| Q1 2021 | $292,000 | -66.7% | 23,280 | -74.9% | 0.01% | -65.9% |
| Q3 2020 | $877,000 | +23.2% | 92,845 | +16.9% | 0.04% | +13.9% |
| Q2 2020 | $712,000 | – | 79,424 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
| NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
| Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
| WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
| Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
| Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
| Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
| Leisure Capital Management | 43,008 | $131,000 | 0.12% |
| Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |